MedPath

CXA-10

Generic Name
CXA-10
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C18H33NO4
CAS Number
875685-46-4
Unique Ingredient Identifier
1N19AGY57Y
Background

CXA-10 is under investigation in clinical trial NCT03422510 (FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)).

Associated Conditions
-
Associated Therapies
-

Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma

Phase 2
Recruiting
Conditions
Obesity
Asthma
Interventions
Drug: Matching Placebo
Drug: CXA-10
First Posted Date
2018-12-03
Last Posted Date
2024-03-04
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
60
Registration Number
NCT03762395
Locations
🇺🇸

University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath